Question 1

How many shares of SVA does WELLS FARGO & COMPANY/MN own?

Accepted Answer

As of 2026-Q2, WELLS FARGO & COMPANY/MN holds 4,580 shares of SVA (SINOVAC BIOTECH LTD).

Question 2

What is WELLS FARGO & COMPANY/MN's SVA position worth?

Accepted Answer

As of 2026-Q2, WELLS FARGO & COMPANY/MN's SVA position is worth $29,632.

Question 3

Is WELLS FARGO & COMPANY/MN buying or selling SVA?

Accepted Answer

In 2026-Q2, WELLS FARGO & COMPANY/MN decreased their SVA position (-4.8% change in shares).

Question 4

When did WELLS FARGO & COMPANY/MN first buy SVA?

Accepted Answer

Based on available 13F filings, WELLS FARGO & COMPANY/MN first reported a position in SVA in 2024-Q3. They have held the position across 10 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	4,580	-4.8%	$29,632	0.0%	$6.47	0
2026-Q1	Decreased	4,811	-71.5%	$31,127	0.0%	$6.47	0
2025-Q4	Unchanged	16,876	0.0%	$109,188	0.0%	$6.47	0
2025-Q3	Increased	16,876	+0.1%	$109,188	0.0%	$6.47	15
2025-Q2	New	16,851	-	$109,026	0.0%	—	33
2024-Q3	Exited	0	-100.0%	$0	0.0%	—	0

SVAShowing 6 of 10 quarters

SVA
Showing 6 of 10 quarters